DYNAGEN INC
10QSB, EX-3.2, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DYNAGEN INC, 10QSB, 2000-08-14
Next: DYNAGEN INC, 10QSB, EX-3.3, 2000-08-14




                                                                     EXHIBIT 3.2
                                                                     -----------



                            CERTIFICATE OF AMENDMENT

                                       OF

                          CERTIFICATE OF INCORPORATION

                                       OF

                                  DYNAGEN, INC.

         It is hereby certified that:

         1. The name of the corporation (hereinafter called the "Corporation")
is DynaGen, Inc.

         2. The Restated Certificate of Incorporation of the Corporation is
hereby amended by deleting the first paragraph of Paragraph 4 thereunder and
inserting in its place the following paragraph:

                           4. The total number of shares of stock which the
                  corporation shall have authority to issue is 135,000,000
                  shares, consisting of 125,000,000 shares of common stock,
                  having a par value of $0.01 per share (the "Common Stock"),
                  and 10,000,000 shares of preferred stock, having a par value
                  of $0.01 per share (the "Preferred Stock").

         3. The amendment to the Restated Certificate of Incorporation herein
certified has been duly adopted in accordance with Section 242 of the General
Corporation Law of the State of Delaware.

         IN WITNESS WHEREOF, DynaGen, Inc. has caused this certificate to be
signed by C. Robert Cusick, its President, thereto duly authorized, this 31st
day of May, 2000.


                                                 DYNAGEN, INC.


                                                 By: /s/ C. Robert Cusick
                                                     --------------------
                                                     C. Robert Cusick
                                                     President



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission